Literature DB >> 11682667

A prospective study of complications associated with cuffed, tunnelled haemodialysis catheters.

M A Little1, A O'Riordan, B Lucey, M Farrell, M Lee, P J Conlon, J J Walshe.   

Abstract

BACKGROUND: Despite the US Dialysis Outcome Quality Initiative )DOQI( guidelines, for various reasons, increasing numbers of end-stage renal disease patients are becoming dependent on cuffed haemodialysis catheters (HCs) for chronic haemodialysis access. Their use is complicated by frequent failure due to thrombosis and catheter-related sepsis. In our unit, all HCs are put in place by the radiology department.
METHODS: In a prospective study we looked at the outcome of all HCs over a three-year period, during which time 573 consecutive HCs were placed in 336 patients. Each line was followed individually until it was removed or until the end of the study.
RESULTS: In a survival analysis of those HCs removed following HC failure, HC half-life was 312 days and one-year HC survival was 47.5%. The most frequent indications for HC removal were non-function (36.6%), clinical suspicion of line sepsis (16.4%) and patient death (14.4%). Using a Cox proportional hazards model, catheter number in a given patient and the presence of diabetes mellitus were found to be independent predictors of HC failure. The total incidence of HC-related sepsis was 1.3 episodes/1000 catheter days. The probability of developing bacteraemic HC-related sepsis was 27.5% at one year.
CONCLUSIONS: Less than half of the HCs were removed electively because of availability of a more permanent mode of renal replacement, thereby illustrating the level of dependence that has developed on them as permanent access. Consequently, their limitations (infection and malfunction) are placing an ever increasing burden on the healthcare services.

Entities:  

Mesh:

Year:  2001        PMID: 11682667     DOI: 10.1093/ndt/16.11.2194

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  17 in total

1.  Low-intensity adjusted-dose warfarin for the prevention of hemodialysis catheter failure: a randomized, controlled trial.

Authors:  Trevor J Wilkieson; Alistair J Ingram; Mark A Crowther; Steven D Soroka; Ryuta Nagai; Kailash K Jindal; Catherine M Clase
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-14       Impact factor: 8.237

2.  Improvement of hemodialysis catheter function with tenecteplase: a phase III, open-label study: TROPICS 4.

Authors:  Steven Fishbane; Samuel L Milligan; Kenneth D Lempert; Joachim E W Hertel; James B Wetmore; Matthew J Oliver; Martha Blaney; Barbara S Gillespie; Joan R Jacobs; Susan M Begelman
Journal:  J Thromb Thrombolysis       Date:  2011-01       Impact factor: 2.300

3.  An economic evaluation of rt-PA locking solution in dialysis catheters.

Authors:  Braden J Manns; Nairne Scott-Douglas; Marcello Tonelli; Pietro Ravani; Martine LeBlanc; Marc Dorval; Rachel Holden; Louise Moist; Charmaine Lok; Deborah Zimmerman; Flora Au; Brenda R Hemmelgarn
Journal:  J Am Soc Nephrol       Date:  2014-07-10       Impact factor: 10.121

4.  Choice of Hemodialysis Access in Older Adults: A Cost-Effectiveness Analysis.

Authors:  Rasheeda K Hall; Evan R Myers; Sylvia E Rosas; Ann M O'Hare; Cathleen S Colón-Emeric
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-18       Impact factor: 8.237

5.  Natural history of tunneled dialysis catheters placed for hemodialysis initiation.

Authors:  Roman Shingarev; Jill Barker-Finkel; Michael Allon
Journal:  J Vasc Interv Radiol       Date:  2013-07-18       Impact factor: 3.464

Review 6.  Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease.

Authors:  Ying Wang; Jessica N Ivany; Vlado Perkovic; Martin P Gallagher; Mark Woodward; Meg J Jardine
Journal:  Cochrane Database Syst Rev       Date:  2016-04-04

7.  Effectiveness and Cost of Weekly Recombinant Tissue Plasminogen Activator Hemodialysis Catheter Locking Solution.

Authors:  Brenda R Hemmelgarn; Braden J Manns; Steven D Soroka; Adeera Levin; Jennifer MacRae; Karthik Tennankore; Jo-Anne S Wilson; Robert G Weaver; Pietro Ravani; Robert R Quinn; Marcello Tonelli; Mercedeh Kiaii; Paula Mossop; Nairne Scott-Douglas
Journal:  Clin J Am Soc Nephrol       Date:  2018-01-15       Impact factor: 8.237

Review 8.  Interventions for treating central venous haemodialysis catheter malfunction.

Authors:  Alice L Kennard; Giles D Walters; Simon H Jiang; Girish S Talaulikar
Journal:  Cochrane Database Syst Rev       Date:  2017-10-26

9.  Patterns of Hemodialysis Catheter Dysfunction Defined According to National Kidney Foundation Guidelines As Blood Flow <300 mL/min.

Authors:  Robert I Griffiths; Britt B Newsome; Geoffrey A Block; Robert J Herbert; Mark D Danese
Journal:  Int J Nephrol       Date:  2011-12-08

Review 10.  Antimicrobial lock solutions for preventing catheter-related infections in haemodialysis.

Authors:  Maria C Arechabala; Maria I Catoni; Juan Carlos Claro; Noelia P Rojas; Miriam E Rubio; Mario A Calvo; Luz M Letelier
Journal:  Cochrane Database Syst Rev       Date:  2018-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.